Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest in this topic

  1. Pharmacologic reversal of advanced Alzheimer's disease in mice and identification of potential therapeutic nodes in human brain 2025-12-22
  2. Similar brain proteomic signatures in Alzheimer's disease and epilepsy 2024-01-30
  3. Associations between brain inflammatory profiles and human neuropathology are altered based on apolipoprotein E ε4 genotype 2020-02-19

Studies

9 studies carry this tag.

Date range

1999 to 2025

Top journals

  • Acta neuropathologica 1
  • Cell and tissue research 1
  • Cell reports. Medicine 1
  • Electrophoresis 1
  • Frontiers in aging neuroscience 1

9 journals in all.

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Pharmacologic reversal of advanced Alzheimer's disease in mice and identification of potential therapeutic nodes in human brain

    ✓ Peer-reviewed alzhub usefulness score 47 out of 100. Cell reports. Medicine 2025-12-22 Biomarkers

    Alzheimer's disease (AD) is traditionally considered irreversible.

  2. Similar brain proteomic signatures in Alzheimer's disease and epilepsy

    ✓ Peer-reviewed alzhub usefulness score 48 out of 100. Acta neuropathologica 2024-01-30 Biomarkers

    The prevalence of epilepsy is increased among Alzheimer's Disease (AD) patients and cognitive impairment is common among people with epilepsy.

  3. Associations between brain inflammatory profiles and human neuropathology are altered based on apolipoprotein E ε4 genotype

    ✓ Peer-reviewed alzhub usefulness score 53 out of 100. Scientific reports 2020-02-19 Genetics

    Alzheimer disease (AD) is a chronic neurodegenerative disease with a multitude of contributing genetic factors, many of which are related to inflammation.

  4. Myeloperoxidase-immunoreactive cells are significantly increased in brain areas affected by neurodegeneration in Parkinson's and Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Cell and tissue research 2017-05-02 Biomarkers

    Myeloperoxidase (MPO) is a key enzyme in inflammatory and degenerative processes, although conflicting reports have been presented concerning its expression in the brain.

  5. Increased acetyl and total histone levels in post-mortem Alzheimer's disease brain

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Neurobiology of disease 2014-12-05 Biomarkers

    Histone acetylation is an epigenetic modification that plays a critical role in chromatin remodelling and transcriptional regulation.

  6. Amyloid Beta1-42 and the Phoshorylated Tau Threonine 231 in Brains of Aged Cynomolgus Monkeys (Macaca fascicularis)

    ✓ Peer-reviewed alzhub usefulness score 40 out of 100. Frontiers in aging neuroscience 2014-11-10 Biomarkers

    Pathological hallmarks indicative of Alzheimer's disease (AD), which are the plaques of amyloid beta1-42 and neurofibrillary tangles, were found in brain of aged cynomolgus monkey.

  7. Chronic nicotine treatment reduces beta-amyloidosis in the brain of a mouse model of Alzheimer's disease (APPsw)

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Journal of neurochemistry 2002-05-01 Biomarkers

    Alzheimer's disease neuropathology is characterised by beta-amyloid plaques and neurofibrillary tangles.

  8. Decreased levels of synaptosomal associated protein 25 in the brain of patients with Down syndrome and Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Electrophoresis 1999-04-01 Biomarkers

    Synaptosomal associated protein 25 kDa (snap-25) is a widely distributed membrane-associated protein in the brain, mainly localized in nerve terminals.

  9. Activities of key glycolytic enzymes in the brains of patients with Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Journal of neural transmission (Vienna, Austria : 1996) 1999-01-01 Biomarkers

    The activities of hexokinase, aldolase, pyruvate kinase, lactate dehydrogenase and glucose 6-phosphate dehydrogenase were determined in brains of patients with Alzheimer's disease (AD) and in age matched controls.

All topic tags with their study counts